Brian T Lee MD
@briantleemd
Followers
679
Following
726
Media
29
Statuses
313
Adult Hepatologist / Interest: Allo+Autoimmune Dz / T&RT represent me / #LiverTwitter #TransplantTwitter
Newport Beach, CA
Joined February 2020
We also looked at the effects of ascites and HE with MELD 3.0 - the sicker than MELD patients with ascites/HE still struggle in the 3.0 era. #LiverTwitter.
journals.lww.com
the impact of ascites and HE and its interaction with MELD 3.0 on waitlist mortality. Methods. This is a retrospective study of patients listed for LT in the Organ Procurement and Transplantation...
0
1
4
Great study on not forgetting your roots - while ascites/HE have been removed from objective mortality prediction/LT prioritization, it shouldn’t be forgotten from predicting mortality and prioritizing medical care/LT in clinical practice. #LiverTwitter.
Enhancement of Cirrhosis Mortality Prediction by Including Hepatic Encephalopathy to MELD 3.0 in a National Veteran Cohort.Silvey, et al. 📕 @nilangpatel @DrJackieOleary @JasmohanBajaj @MLongMD.
1
4
7
Most assessments in alcohol-associated liver disease are in the short-term of 1-6 months. This study looks at the natural history of ALD long-term. @AmJGastro .
journals.lww.com
n in the longer term, taking nonliver mortality into account. METHODS: The WALDO cohort includes 734 patients with biopsy-proven ALD. Prognostic scores were assessed with dynamic area under the curve...
0
4
7
Wonder how many new customers are actually old customers of alcoholic beer?. Also found the IWSR report interesting on “casual consumption.”. Lots of changes in drinking patterns and will be interesting to see their global effects on ALD #LiverTwitter
Non-alcoholic beer to overtake ale as the second-largest beer category worldwide this year, per CNBC.
0
1
3
Curious how all of you respond when your ALD patients say “I’ve switched over to non-alcoholic beer.” Or wine. #LiverTwitter.
Overall beer volume has fallen roughly 1% in 2024, volume for its non-alcoholic counterpart grew 9% worldwide, per CNBC.
3
1
1
Lean MASH, PBF 19%, ruled out most secondary causes - apart from trying to test PNPLA3, if the patient can afford the assay ($200-400 USD), how do you counsel and manage your lean MASH patients? #LiverTwitter.
0
0
3
Just dropped: the Transplant Hepatologist Action Figure. No liver left behind 👊💥. Adding to my collection 😂. #LiverTwitter #LiverHero #TIPSNotIncluded
4
6
56
Any experiences or tips on streamlining your MASLD referrals? . In the midst of building a dot phrase in Epic for the FIB-4. I’m curious how other centers are dealing with the volume of MASLD referrals to Hepatology, please share! I would love to learn. #LiverTwitter.
1
0
11
And yes, we set up a podcast-like stage for Q&As and case discussions 😄. It went over really well!.
0
0
4
This weekend, I had the privilege of directing the 3rd annual Digestive Health Symposium for @hoaghealth. We were blessed with the presence of @geneyim in learning about ALD for our keynote address. Overall, super fun and educational. Thankful to our organizers and attendees!
2
0
19
Thank you @doximity . I used to get 8-10 spam calls a day. Nowadays, down to 2-3. This was also free! So thankful 🙏
0
2
17
Back to writing again - check out new article on ascites/HE in MELD 3.0. New scoring systems are necessary in achieving equity but clinical observation is still key in identifying those in need, transplant or not. @TXPDirect . #LiverTwitter.
journals.lww.com
the impact of ascites and HE and its interaction with MELD 3.0 on waitlist mortality. Methods. This is a retrospective study of patients listed for LT in the Organ Procurement and Transplantation...
1
2
8
Been awhile Twitter aka X!. Consult today: lactobacillus in the ascitic fluid of a cirrhotic patient with SBP. Takes probiotics at home. I’ve only seen this one other time during residency. Probiotics in cirrhosis - thoughts? #LiverTwitter.
0
2
10
3
0
13
“Walking in a Liver Wonderland”…my fav time of year ☺️. See you in Boston!. This year, I did sign up for the @_ILTS_ course. Liver transplant is entering an interesting era with machine perfusion, ventures into transplant oncology, precision med in rejection. Fun! #TLM23.
There’s still time to save! Join over 7,000 #hepatology enthusiasts Nov. 10-14 in Boston. This is your last chance to act before registration rates increase to the full price. Save 15% and register by Wednesday, Oct. 18. View the official program: #TLM23
1
0
11
YES WE LOVE LIVER SOCKS.
0
0
3
Who wants to guess my transaminases on mile 26? Marathons are rough. Ouch.
4
0
19